Inv16 P13q22 T1616P13q22 Gene Rearrangement Quantitative MRD Monitor Test
Introduction
The Inv16 P13q22 T1616P13q22 Gene Rearrangement Quantitative MRD Monitor Test is a state-of-the-art diagnostic tool employed in the field of molecular diagnostics. This test plays a pivotal role in the management of cancer by allowing healthcare providers to monitor minimal residual disease (MRD) in patients who have undergone treatment. By detecting residual cancer cells, oncologists and hematologists can make informed decisions regarding further treatment options.
What the Test Measures
This test quantitatively measures specific gene rearrangements associated with malignancies, particularly in patients diagnosed with cancers such as acute myeloid leukemia (AML). It utilizes Real Time PCR technology to provide accurate and reliable results, which are essential for assessing treatment response and disease status.
Who Should Consider This Test
Patients who have been diagnosed with cancer and are undergoing treatment should consider this test. It is particularly beneficial for those experiencing symptoms such as:
- Unexplained fatigue
- Frequent infections
- Unintentional weight loss
- Persistent fever
Additionally, individuals with risk factors such as a family history of cancer or previous cancer diagnoses should also discuss this test with their healthcare provider.
Benefits of Taking the Test
- Monitors treatment efficacy and disease progression
- Facilitates timely intervention if residual disease is detected
- Helps in personalizing treatment plans based on individual patient data
- Provides peace of mind for patients and their families
Understanding Your Results
Results from the Inv16 P13q22 T1616P13q22 Gene Rearrangement Quantitative MRD Monitor Test will be provided in a clear and concise format. Your healthcare provider will explain what the results mean in the context of your treatment and overall health, helping you understand the next steps in your care plan.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| Inv16 P13q22 T1616P13q22 Gene Rearrangement Quantitative MRD Monitor Test | 15,000 KSh | 20,000 KSh |
Sample Collection and Instructions
The sample for this test is a 5 mL (3 mL min.) whole blood or bone marrow collected in a Lavender Top (EDTA) tube. It is crucial to ship the sample refrigerated and to avoid freezing. Please ensure that a duly filled MRD Requisition form (Form 22) with historical data is included, as this is mandatory for processing your test.
Availability
We have branches across all major cities in Kenya, including Nairobi, Mombasa, and Kisumu, making it convenient for you to access our services. We also offer home sample collection services for your convenience.
Book Your Test Today!
Don’t wait to monitor your health. Book the Inv16 P13q22 T1616P13q22 Gene Rearrangement Quantitative MRD Monitor Test now by calling or WhatsApp us at +254746849631. Your health is our priority!
